Preparation, characterization, and in vivo evaluation of tanshinone IIA solid dispersions with silica nanoparticles

References

• WangPWuXBaoYTSIIA prevents cardiac remodeling through attenuating NAD (P)H oxidase-derived reactive oxygen species production in hypertensive ratsPharmazie201166751752421812327
   PubMed Web of Science ®Google Scholar
• SunDDWangHCWangXBTanshinone IIA: a new activator of human cardiac KCNQ1/KCNE1 (I(Ks)) potassium channelsEur J Pharmacol20085901–331732118573250
   PubMed Web of Science ®Google Scholar
• GaoJYangGPiRTanshinone IIA protects neonatal rat cardiomyocytes from adriamycin-induced apoptosisTransl Res20081512798718201675
   PubMed Web of Science ®Google Scholar
• FuJHuangHLiuJPiRChenJLiuPTSIIA protects cardiac myocytes against oxidative stress-triggered damage and apoptosisEur J Pharmacol20075681–321322117537428
   PubMed Web of Science ®Google Scholar
• HaoHWangGCuiNLiJXieLDingZPharmacokinetics, absorption and tissue distribution of tanshinone IIA solid dispersionPlanta Med200672141311131717024606
   PubMed Web of Science ®Google Scholar
• LiJWangGLiPHaoHSimultaneous determination of tanshinone IIA and cryptotanshinone in rat plasma by liquid chromatography-electrospray ionization-mass spectrometryJ Chromatogr B Analyt Technol Biomed Life Sci20058261–22630
   Web of Science ®Google Scholar
• YuHSubediRKNepalPREnhancement of solubility and dissolution rate of cryptotanshinone, tanshinone I and tanshinone IIA extracted from Salvia miltiorrhizaArch Pharm Res20123581457146422941489
   PubMed Web of Science ®Google Scholar
• YuXYLinSGZhouZWRole of P-glycoprotein in the intestinal absorption of tanshinone IIA, a major active ingredient in the root of Salvia miltiorrhiza BungeCurr Drug Metab20078432534017504222
   PubMed Web of Science ®Google Scholar
• MaoSJHouSXLiangZIon-pair reversed-phase HPLC: assay validation of sodium IIA sulfonate in mouse plasmaJ Chromatogr B Analyt Technol Biomed Life Sci20068311–2163168
   PubMed Web of Science ®Google Scholar
• WangLJiangXXuWLiCComplexation of tanshinone IIA with 2- hydroxypropyl-beta-cyclodextrin: effect on aqueous solubility, dissolution rate, and intestinal absorption behavior in ratsInt J Pharm20073411–2586717482783
   PubMed Web of Science ®Google Scholar
• VasconcelosTSarmentoBCostaPSolid dispersions as strategy to improve oral bioavailability of poor water soluble drugsDrug Discov Today20071223–241068107518061887
   PubMed Web of Science ®Google Scholar
• LennernäsHAbrahamssonBThe use of biopharmaceutic classification of drugs in drug discovery and development: current status and future extensionJ Pharm Pharmacol200557327328515807982
   PubMed Web of Science ®Google Scholar
• LeunerCDressmanJImproving drug solubility for oral delivery using solid dispersionsEur J Pharm Biopharm2000501476010840192
   PubMed Web of Science ®Google Scholar
• StreubelASiepmannJBodmeierRDrug delivery to the upper small intestine window using gastroretentive technologiesCurr Opin Pharmacol20066550150816890020
   PubMed Web of Science ®Google Scholar
• TanakaNImaiKOkimotoKDevelopment of novel sustained-release system, disintegration-controlled matrix tablet (DCMT) with solid dispersion granules of nilvadipine (II): in vivo evaluationJ Control Release20061121515616545477
   PubMed Web of Science ®Google Scholar
• ShiFZhaoJHLiuYWangZZhangYTFengNPPreparation and characterization of solid lipid nanoparticles loaded with frankincense and myrrh oilInt J Nanomedicine201272033204322619540
   PubMed Web of Science ®Google Scholar
• KashanianSAzandaryaniAHDerakhshandehKNew surface-modified solid lipid nanoparticles using N-glutaryl phosphatidylethanolamine as the outer shellInt J Nanomedicine201162393240122114489
   PubMed Web of Science ®Google Scholar
• LiJLiuPLiuJPZhangWLYangJKFanYQNovel Tanshinone IIA ternary solid dispersion pellets prepared by a single-step technique: in vitro and in vivo evaluationEur J Pharm Biopharm201280242643222119664
   PubMed Web of Science ®Google Scholar
• Parmar KomalRSatapara VijayPShah SunnyRSheth NavinRImprovement of dissolution properties of lamotrigine by inclusion complexation and solid dispersion techniquePharmazie201166211912321434574
   PubMed Web of Science ®Google Scholar
• KimMSKimJSParkHJChoWKChaKHHwangSJEnhanced bioavailability of sirolimus via preparation of solid dispersion nanoparticles using a supercritical antisolvent processInt J Nanomedicine201162997300922162657
   PubMed Web of Science ®Google Scholar
• LöbenbergRAmidonGLModern bioavailability, bioequivalence and biopharmaceutics classification system: New scientific approaches to international regulatory standardsEur J Pharm Biopharm200050131210840189
   PubMed Web of Science ®Google Scholar
• JunghannsJUMüllerRHNanocrystal technology, drug delivery and clinical applicationsInt J Nanomedicine20083329530918990939
   PubMed Web of Science ®Google Scholar
• BikiarisDPapageorgiouGZStergiouAPhysicochemical studies on solid dispersions of poorly water-soluble drugs: evaluation of capabilities and limitations of thermal analysis techniquesThermochim Acta20054391–25867
   Web of Science ®Google Scholar
• HeXQPeiLXTongHHZhengYComparison of spray freeze drying and the solvent evaporation method for preparing solid dispersions of baicalein with Pluronic F68 to improve dissolution and oral bioavailabilityAAPS Pharm Sci Tech2011121104113
   PubMed Web of Science ®Google Scholar
• KaravasEKtistisGXenakisAGeorgarakisEEffect of hydrogen bonding interactions on the release mechanism of felodipine from nanodispersions with polyvinylpyrrolidoneEur J Pharm Biopharm200663210311416675209
   PubMed Web of Science ®Google Scholar
• PokharkarVBMandpeLPPadamwarMNAmbikeAAMahadikKRParadkarADevelopment, characterization and stabilization of amorphous form of a low Tg drugPowder Technol200616712025
   Web of Science ®Google Scholar
• YangCXuXWangJAnZUse of the co-grinding method to enhance the dissolution behavior of a poorly water-soluble drug: generation of solvent-free drug-polymer solid dispersionsChem Pharm Bull (Tokyo)201260783784522790815
   PubMed Web of Science ®Google Scholar
• KolašinacNKachrimanisKHomšekIGrujićBDurićZIbrićSSolubility enhancement of desloratadine by solid dispersion in poloxamersInt J Pharm20124361–216117022772487
   PubMed Web of Science ®Google Scholar
• BleyHFussneggerBBodmeierRCharacterization and stability of solid dispersions based on PEG/polymer blendsInt J Pharm2010390216517320132875
   PubMed Web of Science ®Google Scholar
• ZhaoXLiuXGanLZhouCMoJPreparation and physicochemical characterizations of tanshinone IIA solid dispersionArch Pharm Res201134694995921725816
   PubMed Web of Science ®Google Scholar
• JondhaleSBhiseSPoreYPhysicochemical investigations and stability studies of amorphous gliclazideAAPS Pharm Sci Tech2012132448459
   PubMed Web of Science ®Google Scholar
• MellaertsRMolsRJammaerJAIncreasing the oral bioavailability of the poorly water soluble drug itraconazole with ordered mesoporous silicaEur J Pharm Biopharm200869122323018164930
   PubMed Web of Science ®Google Scholar
• TakeuchiHNagiraSYamamotoHKawashimaYSolid dispersion particles of amorphous indomethacin with fine porous silica particles by using spray-drying methodInt J Pharm20052931–215516415778053
   PubMed Web of Science ®Google Scholar
• TakeuchiHNagiraSTanimuraSYamamotoHKawashimaYTabletting of solid dispersion particles consisting of indomethacin and porous silica particlesChem Pharm Bull (Tokyo)200553548749115863917
   PubMed Web of Science ®Google Scholar
• TakeuchiHHandaTKawashimaYSpherical solid dispersion containing amorphous tolbutamide embedded in enteric coating polymers or colloidal silica prepared by spray-drying techniqueChem Pharm Bull (Tokyo)1987359380038062830037
   PubMed Web of Science ®Google Scholar
• MonkhouseDCLachJLUse of adsorbents in enhancement of drug dissolution. IIJ Pharm Sci1972619143514414341625
   PubMed Web of Science ®Google Scholar
• ChauhanBShimpiSParadkarAPreparation and evaluation of glibenclamide-polyglycolized glycerides solid dispersions with silicon dioxide by spray drying techniqueEur J Pharm Sci200526221923016087324
   PubMed Web of Science ®Google Scholar
• ChenBWangZQuanGIn vitro and in vivo evaluation of ordered mesoporous silica as a novel adsorbent in liquisolid formulationInt J Nanomedicine2012719920922275835
   PubMed Web of Science ®Google Scholar
• DuXHeJSpherical silica micro/nanomaterials with hierarchical structures: synthesis and applicationsNanoscale20113103984400221918775
   PubMed Web of Science ®Google Scholar
• CaoXDengWWFuMIn vitro release and in vitro-in vivo correlation for silybin meglumine incorporated into hollow-type mesoporous silica nanoparticlesInt J Nanomedicine2012775376222393284
   PubMed Web of Science ®Google Scholar
• GalagudzaMMKorolevDVSoninDLTargeted drug delivery into reversibly injured myocardium with silica nanoparticles: surface functionalization, natural biodistribution, and acute toxicityInt J Nanomedicine2010523123720463939
   PubMed Web of Science ®Google Scholar
• CorbalanJJMedinaCJacobyAMalinskiTRadomskiMWAmorphous silica nanoparticles aggregate human platelets: potential implications for vascular homeostasisInt J Nanomedicine2012763163922334785
   PubMed Web of Science ®Google Scholar
• GalagudzaMKorolevDPostnovVPassive targeting of ischemic-reperfused myocardium with adenosine-loaded silica nanoparticlesInt J Nanomedicine201271671167822619519
   PubMed Web of Science ®Google Scholar
• ThoILiepoldBRosenbergJMaegerleinMBrandlMFrickerGFormation of nano/micro-dispersions with improved dissolution properties upon dispersion of ritonavir melt extrudate in aqueous mediaEur J Pharm Sci2010401253220172027
   PubMed Web of Science ®Google Scholar
• WangLCuiFDSunadaHPreparation and evaluation of solid dispersions of nitrendipine prepared with fine silica particles using the melt-mixing methodChem Pharm Bull (Tokyo)2006541374316394546
   PubMed Web of Science ®Google Scholar
• YassinAEAlanaziFKEl-BadryMAlsarraIABarakatNSAlanaziFKPreparation and characterization of spironolactone-loaded gelucire microparticles using spray-drying techniqueDrug Dev Ind Pharm200935329730418821154
   PubMed Web of Science ®Google Scholar
• Van EerdenbrughBVan SpeybroeckMMolsRItraconazole/TPGS/Aerosil200 solid dispersions: characterization, physical stability and in vivo performanceEur J Pharm Sci200938327027819686846
   PubMed Web of Science ®Google Scholar
• KimMSKimJSParkHJChoWKChaKHHwangSJEnhanced bioavailability of sirolimus via preparation of solid dispersion nanoparticles using a supercritical antisolvent processInt J Nanomedicine201162997300922162657
   PubMed Web of Science ®Google Scholar
• GuedesFLde OliveiraBGHernandesMZSolid dispersions of imidazolidinedione by PEG and PVP polymers with potential antischistosomal activitiesAAPS Pharm Sci Tech2011121401410
   Web of Science ®Google Scholar
• JondhaleSBhiseSPoreYPhysicochemical investigations and stability studies of amorphous gliclazideAAPS Pharm Sci Tech2012132448459
   PubMed Web of Science ®Google Scholar
• VippaguntaSRMaulKATallavajhalaSGrantDJSolid state characterization of nifedipine solid dispersionsInt J Pharm20022361–211112311891075
   PubMed Web of Science ®Google Scholar
• KawabataYYamamotoKDebariKOnoueSYamadaSNovel crystalline solid dispersion of tranilast with high photostability and improved oral bioavailabilityEur J Pharm Sci201039425626220038453
   PubMed Web of Science ®Google Scholar
• JunghannsJUMüllerRHNanocrystal technology, drug delivery and clinical applicationsInt J Nanomedicine20083329530918990939
   PubMed Web of Science ®Google Scholar
• LiJLiuPLiuJPZhangWLYangJKFanYQNovel Tanshinone IIA ternary solid dispersion pellets prepared by a single-step technique: in vitro and in vivo evaluationEur J Pharm Biopharm201280242643222119664
   PubMed Web of Science ®Google Scholar
• WangLLuAWangCZhengXZhaoDLiuRNano-fibriform production of silica from natural chrysotileJ Colloid Interface Sci2006295243643916212972
   PubMed Web of Science ®Google Scholar
• PlaninšekOKovačičBVrečerFCarvedilol dissolution improvement by preparation of solid dispersions with porous silicaInt J Pharm20114061–2414821219991
   PubMed Web of Science ®Google Scholar
• LeunerCDressmanJImproving drug solubility for oral delivery using solid dispersionsEur J Pharm Biopharm2000501476010840192
   PubMed Web of Science ®Google Scholar
• HuKLCaoSHuFQFengJFEnhanced oral bioavailability of docetaxel by lecithin nanoparticles: preparation, in vitro, and in vivo evaluationInt J Nanomedicine201273537354522848177
   PubMed Web of Science ®Google Scholar
• TangFLiLChenDMesoporous silica nanoparticles: synthesis, biocompatibility and drug deliveryAdv Mater201224121504153422378538
   PubMed Web of Science ®Google Scholar
• FalahatiMSabouryAAMa’maniLShafieeARafieepourHAThe effect of functionalization of mesoporous silica nanoparticles on the interaction and stability of confined enzymeInt J Biol Macromol20125041048105422421216
   PubMed Web of Science ®Google Scholar
• GalagudzaMKorolevDPostnovVPassive targeting of ischemic-reperfused myocardium with adenosine-loaded silica nanoparticlesInt J Nanomedicine201271671167822619519
   PubMed Web of Science ®Google Scholar
• CheangTYTangBXuAWPromising plasmid DNA vector based on APTES-modified silica nanoparticlesInt J Nanomedicine201271061106722403488
   PubMed Web of Science ®Google Scholar